Cancer

Judy Ou, PhD, MPH, is an epidemiologist-which is, according to her, "the nerdiest kind of detective ever."

Living cells are one of the few materials that can replicate themselves, and this is crucial for tissue development and recovering from injury or illness.

A new review was published in Volume 13 of Oncoscience on September 30, 2026, titled "Extracellular vesicles in health, aging and disease."

The University of Texas MD Anderson Cancer Center today announced the historic expansion of its Texas Medical Center (TMC) campus through two new facilities: Inspiration Tower and Prism.

Doctors said that women should receive treatment for menopause symptoms, but need accurate information about the drugs.

Doctors said that women should receive treatment for menopause symptoms, but need accurate information about the drugs.

NYU Grossman School of Medicine researchers found that DNA-copying problems at a small set of chromosome sites can determine how cancer cells respond to PARP inhibitors, pointing to possible biomarkers of drug sensitivity. The post Where DNA Copying Fails Can Decide How Cancer Cells Respond to PARP Inhibitors appeared first on GEN - Genetic Engineering and Biotechnology News.

The results of a study found that women with higher blood levels of two common PFAS were more likely to develop estrogen receptor-negative breast cancer, saying their results have important public health implications. The post ER-Negative Breast Cancer Risk Linked with Blood Levels of Two PFAS Forever Chemicals appeared first on GEN - Genetic Engineering and Biotechnology News.

Women with higher blood levels of two common per- and polyfluoroalkyl substances, also familiarly known as PFAS, were more likely to develop estrogen receptor-negative, or ER-negative, breast cancer, according to a new study by the National Institutes of Health (NIH), part of the U.S. Department of Health and Human Services (HHS).

FRIDAY, Nov. 6, 2026 — Two “forever chemicals” have been linked to a more deadly form of breast cancer, a new study says.Women with higher blood levels of the two common per- and polyfluoroalkyl substances (PFAS) are more likely to develop a...

The change marks another dramatic shift in how ASTRO advises patients receive EBRT and has the potential to substantially lower treatment burdens for patients.

Emmy-winning actress Susan Saint James died of pancreatic cancer at 80. A resurfaced 2010 interview reveals the secret alcohol addiction she overcame through a 12-step programme.

A record 373,574 cancers were diagnosed in England in 2024, but Macmillan says where people live still affects their risk and survival.

Living cells are one of the few materials that can replicate themselves, and this is crucial for tissue development and recovery from injury or illness. But making sure cell division only happens at the right time is essential; otherwise, unregulated replication can lead to problems like cancer.

Updated recommendations favor less extensive surgery for selected early tumors and timely brachytherapy and immunotherapy for some patients with advanced disease.

Updated recommendations favor less extensive surgery for selected early tumors and timely brachytherapy and immunotherapy for some patients with advanced disease.

The latest collaboration will encompass six biologic preclinical programs. Five programs focus on treatments originating with a wholly owned SBP Group subsidiary, LaNova Medicines. The sixth comes from another SBP Group subsidiary, Beijing Tide Pharmaceutical. The post Boehringer Ingelheim Inks Up-to-$7.4B+ Cancer Drug Collaboration with Sino Biopharmaceutical appeared first on GEN - Genetic Engineering and Biotechnology News.

The National Comprehensive Cancer Network (NCCN) today announced the signing of a new agreement with the Viet Nam National Cancer Hospital (K Hospital) and The Vietnam Cancer Association (VCA), expanding a longstanding collaboration to improve cancer care through the adaptation and use of evidence-based clinical practice guidelines.

A small subset of vulnerable DNA sites can make cancer cells highly sensitive to targeted drugs called PARP inhibitors, a new study shows.

As low-cost and straightforward an intervention as automated text messaging could make a significant contribution to tackling London's below-average bowel cancer screening rates, according to a major study led by the University of Surrey.

Forty-five is the new 60 – at least when it comes to colonoscopies. That may not be the party you look forward to, but it could save your life. According to the Cancer Research Institute, 1 in 5 colorectal cancers are diagnosed in patients under age 55, making what was once thought of as an older person's disease one of the fastest-growing cancers in young people.

Analyzing a massive collection of data from 150,000 patient tumor samples, researchers have identified T cell receptors against cancer that are shared across multiple patients.

A triplet combination therapy can remodel the tumor microenvironment in patients with advanced gastric cancer and shows a promising safety profile, according to results from a new phase 2 clinical trial.

A clinical trial in England will for the first time assess whether ⁠family doctors can use simple blood tests to help diagnose some of the most ⁠common cancers earlier and...

Glioblastoma is the deadliest and most common type of malignant brain tumour in adults. One of the reasons it's almost always incurable is that individual tumour cells are very different from one another and shift dynamically between various 'states'.

More than 20,000 patients aged 45 or over with abdominal symptoms will take part in the trial, which runs until October 2031.

The immune system has powerful cells that can recognize and destroy cancer, but this ability can gradually wane when the cells reside within a tumor.

WEDNESDAY, Nov. 4, 2026 — Doctors removing cancers surgically might not need to cut away lots of healthy tissue to make sure they’ve gotten all the tumor, a new study says.For one form of childhood cancer, the chances it might come back can be...

Christa Pike survived Tennessee's failed lethal injection, months after her lawyers warned that a suspected blood disorder and difficult intravenous access could cause severe suffering.

Elevated platelet counts and CRP levels are tied to a risk for cancer among White, Asian, and Black patients in primary care, with stronger associations with colorectal cancer among Black patients.

As many as one fifth of colorectal cancers globally may be attributable to H pylori infection; however, causation remains a question.

Scientists have developed a promising new cancer-fighting strategy that uses carbon monoxide naturally produced by tumor cells to manufacture powerful drugs inside the cancer cells themselves. Early laboratory experiments suggest the technique could selectively attack cancer while sparing healthy cells, potentially paving the way for safer chemotherapy alternatives.

A Rutgers-led consortium has been awarded a $6.5 million grant from the National Cancer Institute (NCI) to support next-generation tools to guide tobacco control policies, improve lung cancer screening, strengthen survivorship care, and support state-level cancer prevention planning.

Researchers have developed a promising new approach that uses synthetic DNA molecules to target cancer-linked genes directly, opening new possibilities for future treatments, diagnostics and biological research.

A new molecular map of breast cancer has identified novel forms of the disease and provides a foundation for selecting personalized treatments guided by a tumor's molecular characteristics rather than standard pathology alone.

Published in Nature Cancer: Researchers at the Université libre de Bruxelles (ULB) have discovered that immune cells build distinct "neighborhoods" around cancer cells.

Researchers have developed a new approach that uses synthetic DNA molecules to target cancer-linked genes directly, opening new possibilities for future treatments, diagnostics and biological research.

Conventional chemotherapy treatments often attack not only cancer cells but also healthy tissue, leading to severe side effects such as hair loss or nausea. The team led by Dr. Thomas Ward from the Department of Chemistry and the Swiss Nanoscience Institute (SNI) at the University of Basel is therefore pursuing an approach that uses artificial metal compounds as catalysts that specifically bind to tumor cells and then convert so-called prodrugs into the active ingredient at the tumor site.

Northwestern Medicine will screen more than 300 firefighters from Chicago and DeKalb, Illinois, for lung cancer through its innovative Lung Health Center at the Canning Thoracic Institute, continuing efforts to detect cancer earlier in populations at increased risk.

Every November, millions worldwide grow mustaches and join Movember, a global movement launched in 2003 to spark conversations about men's health, including prostate cancer, testicular cancer, and mental health.

A new study links GLP-1s to a lower risk of obesity-related cancers, but only compared with drugs often reserved for poorly controlled or advanced diabetes -- raising questions about confounding.

Nicole Taylor, a singer in country group Taylor Red, has died aged 35. Her triplet sisters said she battled breast cancer after her diagnosis in 2022.

A phase 3 trial evaluates the efficacy and safety of anbenitamab plus albumin-bound docetaxel vs docetaxel, trastuzumab, and pertuzumab in patients with HER2-positive advanced breast cancer.

When you’re going through cancer treatment or recovering afterwards, rest might seem like the best medicine.

Genmab’s shares have doubled in three months after a string of cancer drug trial wins, strengthening its push to own more of the medicines it develops.

A multi-institutional collaborative study led by researchers at the University of Chicago and the Fred Hutchinson Cancer Center has identified a previously unknown biological mechanism that controls cell identity and treatment resistance in advanced prostate cancer.

Scientists at the University of North Carolina Lineberger Comprehensive Cancer Center have discovered an unexpected role for a key innate immune protein, revealing how it helps regulate cholesterol levels inside cells and influences tumor growth and treatment response.

When you're going through cancer treatment or recovering afterwards, rest might seem like the best medicine. But research shows that exercise can also play an important role in managing cancer recovery.

A natural plant compound may help overcome a built-in defense that allows many cancers to resist a class of drugs designed to restore normal gene activity, according to a study by researchers at the Johns Hopkins Sidney Kimmel Comprehensive Cancer Center.

In a prospective study of 71,264 Korean women followed for an average of 9.2 years, researchers identified 713 breast cancer cases and examined how different dietary sugar sources related to cancer risk. Women consuming high-sugar foods more than twice weekly had a 28% higher breast cancer risk than those consuming them no more than once a month, while total sugar intake and fruit consumption showed no significant association.

Developing reliable machine learning models for healthcare can be challenging when only small datasets are available. This challenge motivates research into whether quantum computing approaches can learn useful patterns from limited symptom and risk-factor data.

Colorectal cancer is one of the most common cancers in Norway, which also has one of the highest incidence rates in the world.

In a surprising discovery, scientists found that certain diets associated with obesity can make cancer immunotherapy more effective in mice, challenging traditional assumptions about diet and cancer treatment. The findings suggest that the secret may lie in how food interacts with gut bacteria to strengthen the immune system's response to cancer.

A major new study challenges the idea that moderate drinking is safe, finding that even relatively small amounts of alcohol increase the risk of cancer, heart disease, and premature death. Researchers found no overall health benefits from drinking and warn that consuming more than one alcoholic beverage per day can significantly increase long-term health risks.

David Anthony 'Tony' Williams, a 62-year-old father from south London, died less than five months after persistent tiredness led to an acute myeloid leukaemia diagnosis.

Adding irinotecan to adjuvant oxaliplatin-based chemotherapy does not improve 3-year disease-free survival in patients with resected, high-risk stage III colon cancer, a phase 3 trial finds.

An immunotherapy-containing regimen improves event-free survival in a phase 3 trial of patients with locally advanced rectal cancer. But the comparator arm makes it hard to draw conclusions.

The proportion of radiation-treated patients with low-risk prostate cancer has declined across US cohorts, mirroring trends in surgical treatment.

Ciara Mageean, Ireland's European 1,500m champion and two-time Olympian, has died aged 34 after stage four bowel cancer, prompting tributes across Irish athletics.

Scientists at the University of Virginia have developed a promising new strategy to fight glioblastoma, one of the deadliest and most difficult-to-treat forms of brain cancer. Their experimental approach combines focused ultrasound, tiny nanoparticles, and genetic molecules called microRNAs to attack multiple cancer-driving genes simultaneously.

Researchers at Roswell Park Comprehensive Cancer Center have identified a promising strategy for overcoming one of the biggest challenges facing KRAS-targeted cancer therapies: treatment resistance.

Scientists at Johns Hopkins have uncovered a crucial missing link between a common gut bacterium and colorectal cancer, solving a mystery that has puzzled researchers for nearly two decades. The bacterium, Bacteroides fragilis, produces a toxin that damages the colon’s protective lining, triggers chronic inflammation, and promotes tumor formation.

A nanoscale particle with a unique structure, developed at MIT, holds potential as a customizable delivery vehicle for personalized cancer vaccines.

The immune system may recognize a cancer cell and still fail to destroy it. Researchers at Hiroshima University and their international collaborators found that hyperactive YAP and TAZ (YAP/TAZ), two cancer-promoting proteins, were associated with genomic instability that may make cancer cells more recognizable to the immune system, while also increasing PD-L2, which helps the cells suppress T-cell attack.

FRIDAY, Oct. 30, 2026 — A simple vaginal swab may one day help women with abnormal bleeding learn whether they have endometrial cancer without first going through a painful biopsy. The test, from California-based PinkDx, is being studied at...

Researchers at the University of Chicago identified a mechanism to make immune cells reprogrammed by radiation therapy attack tumors rather than protect them.

Fox Chase Cancer Center researchers identified a potential therapeutic target for pancreatic cancer after showing that tumor growth can be slowed and immune suppression can be reduced in preclinical trials by blocking a particular protein, called anoctamin 6 (ANO6).

A nanoscale particle with a unique structure, developed at MIT, holds potential as a customizable delivery vehicle for personalized cancer vaccines. The backbone of the vaccine is a modified, harmless bacteriophage called M13, which forms a nanofiber that can be coated with cancer antigens. By precisely controlling the density of those cancer proteins, the researchers found that they could create a vaccine that prevents the development of colon tumors in mice.

FRIDAY, Oct. 30, 2026 — Nearly 6 in 10 Americans know that boozing increases a person’s odds of cancer, a new survey has found.The findings reflect increased public awareness of studies that link alcohol consumption to cancer, according to experts...

FRIDAY, Oct. 30, 2026 — High-dose omega-3 fatty acid supplements might improve survival among some patients with advanced colon cancer, a new study says.Patients had higher five-year overall survival rates if they took high daily doses of...

The phase 3 trial found the greatest progression-free survival benefit in patients receiving third-line or later treatment, with fewer severe hematologic adverse events.

A study by Leicester researchers shows that the timing of radiotherapy treatment may be as important as how it is given for prostate cancer patients.

Digital CBT for insomnia improves sleep and related symptoms in women with cancer, supporting its wider use in survivorship care.

Researchers here provide a demonstration that a form of liver cancer can emerge from change in the epigenetic control over gene expression in the absence of mutation of nuclear DNA, rather than from mutation of nuclear DNA. It is an interesting open question as to the degree to which aging predisposes to cancer via a growing burden of mutation versus a growing burden of epigenetic change that alters expression of oncogenes. The answer will likely be very different on a tissue by tissue and cancer by cancer basis; biology is complex at every level. Large-scale genome sequencing analyses have identified driver gene mutations (DGMs) in most cancers as well as their associated tumorigenic mechanisms. However, a small fraction of cancers are not positive for these […]

Lloyd Garner, former spotter for Corey Heim, has died aged 54 after battling cancer. Colleagues and drivers paid tribute to his mentorship, humour and lasting impact on motorsports.

Macmillan Cancer Support Jersey publishes its annual report looking back at 2025.

Test results have confirmed his diagnosis as a lung adenocarcinoma that was localised.

The scientists involved say the results could mark a turning point in cancer treatment, bringing personalised medicine a step closer.

Decoding of messenger RNA (mRNA) occurs during translation, the vital cellular process that builds proteins. Errors in this process are known to lead to cancer growth. Scientists at St. Jude Children's Research Hospital identified how one factor involved in mRNA decoding can be altered, identifying potential cancer origins and new targets for KRAS-related treatment resistance. The results are published in Nature Cell Biology.

Cancer survivors face elevated cardiovascular risk, but a heart-healthy diet may help mitigate it, a UK Biobank study suggests.

A previously unknown mechanism helps cancer cells selectively produce proteins that drive tumor growth - such as KRAS - in common cancers, according to new research from The University of Texas MD Anderson Cancer Center.

Dana-Farber Cancer Institute researchers, along with Mass General Brigham researchers from the Gene Lay Institute of Immunology and Inflammation, and the Broad Institute, have uncovered biological clues to why colorectal cancer can behave more aggressively in younger people.

A Florida Walmart worker with testicular cancer says he cannot afford chemotherapy and may die waiting for insurance, highlighting healthcare concerns in a heavily Republican county.

New research in The Journal of Immunology uncovers how high blood sugar (hyperglycemia) and type 1 diabetes (T1D) may protect against certain cancers like melanoma, breast and colon cancer. T1D has been associated with a decreased risk of certain cancers, but the exact reasons why have remained a mystery. New data from studies in mice, now shows that it could be due to changes in immune cells, called T cells, caused by hyperglycemia.

Clinicians must weigh the urgency of cancer treatment against gestational age and coordinate treatment decisions with delivery when pregnancy continues.

Colorectal cancer in young people shows genetic and structural differences that may make it more aggressive and treatment-resistant than the cancer tends to be in older people.

Two trials at the ASCO Quality Care Symposium reach different conclusions on financial navigation, raising questions about best practices in cancer care.

Like most prescriptions, glucagon-like peptide 1 (GLP-1) medications to manage weight come with potential risks.

How cells are arranged within tissue can reveal as much about disease as the cells themselves. When doctors examine a cancer tumor, for example, they don't just look at which cells are present; they also want to know how those cells are arranged and how they interact with each other. That's because the way cancer cells interact with neighboring immune cells can offer important clues about how a disease develops or responds to treatment.

Geron said on Wednesday it would halt a late-stage trial of its blood cancer treatment, ⁠marking a setback for the company's only commercial product, sending its shares...

Cells naturally send tiny packages to one another to share information. Researchers at Carnegie Mellon University have developed a simple, low-cost way to turn those packages into drug carriers that can deliver treatments directly to cancer cells, potentially improving effectiveness while reducing side effects.

Results of a phase 1/2 trial led by Roswell Park Comprehensive Cancer Center show that combining the targeted therapies bevacizumab (Avastin) and pazopanib (Votrient) significantly extends both progression-free and overall survival in patients with the most common type of kidney cancer.

A family of mutations seen in about 20% of human cancers drives malignancy by changing the accessibility of genes to a particular regulatory protein, according to a study by Weill Cornell Medicine investigators.

A team from the Research Institute of the McGill University Health Center (The Institute) have discovered a new type of extracellular vesicle released by migrating cancer cells, revealing a previously unknown way in which these cells shed their DNA as they move. Published today in the journal Nature Cell Biology, the findings show that these cells release tiny structures called motile vesicles (MoVes), which carry their genetic material, including cancer-associated mutations. The discovery raises important questions about the role these vesicles may play in cancer progression.

WEDNESDAY, Oct. 28, 2026 — A personalized cancer vaccine can significantly improve survival odds for patients with advanced melanoma, a new clinical trial has found.Adding the vaccine to immunotherapy after surgery reduced the risk of death or...

WEDNESDAY, Oct. 28, 2026 — Having obesity in your twenties and thirties could raise your risk for early-onset cancer.A team led by Dr. Jae-Seung Yun of The Catholic University of Korea in Seoul followed more than 6 million adults, ages 20 to 39...

Cancer-related discrimination arises from long-lasting cultural and institutional misconceptions, with significant impacts on every part of a person's quality of life and health – and Flinders University researchers say it requires coordinated policy, legal, institutional and public education responses for change to occur.